Speeding up spectroscopic analysis
Ultrafast laser spectroscopy allows the ascertainment of dynamics over extremely short time scales, making it…
Category: Human Health
Fixin’ to be flexitarian: Scrap fish and invasive species can liven up vegetables
Greening the way we eat needn’t mean going vegetarian. A healthy, more realistic solution is…
After 25 years, researchers uncover genetic cause of rare neurological disease
Spinocerebellar ataxia 4 is a devastating progressive movement disease that can begin as early as…
T. Rex not as smart as previously claimed
Dinosaurs were likely as smart as reptiles but not as intelligent as monkeys. Read Original…
Breakthrough in brown fat research: Researchers have found brown fat’s ‘off-switch’
Researchers have found a protein that is responsible for turning off brown fat activity. This…
Probing the effects of interplanetary space on asteroid Ryugu
Samples reveal evidence of changes experienced by the surface of asteroid Ryugu, some probably due…
STAT+: Activist investor Alex Denner, Bioverativ shareholder reach tentative settlement in insider trading case
A tentative settlement has been reached in a long-running shareholder lawsuit that accused health care…
Philips will pay $1.1 billion to resolve U.S. lawsuits over breathing machines that expel debris
WASHINGTON — Medical device maker Philips said Monday it will pay $1.1 billion to settle…
STAT+: Biden administration boosts some Medicaid payments to match commercial rates
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: House bill aimed at Chinese biotechs is advancing
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about MorphoSys drug risks, an AstraZeneca admission, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion
Ono Pharmaceutical of Japan said Monday it will acquire Deciphera Pharmaceuticals, a Boston-based maker of…
STAT+: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs…
Opinion: Medical students lose in the research arms race for residency slots
“Going to medical Spanish class really isn’t worth my time. I’d rather use the time…
.jpg)
STAT+: AI is becoming the exclusive province of academic medicine. A new initiative aims to change that
In Kingman, Ariz., a windswept city of 35,000 at the eastern edge of the Mojave…
There’s never a good time to drink raw milk. But now’s a really bad time as bird flu infects cows
Scientists who know about the types of pathogens — E. coli and Salmonella among them…
Opinion: Unseen battles: The harsh realities of veterans’ access to health care
I remember the day I left the military after six years of active-duty service. The…
STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition
MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for…
Opinion: Déjà WTO: The WHO’s pandemic agreement shouldn’t water down intellectual property obligations
As countries resume final negotiations on Monday for a landmark pandemic agreement intended to help…
Opinion: STAT readers respond to First Opinion essays on site-neutral payments, free medical school tuition, and more
“Former HHS secretaries: Congress should adopt site-neutral payments for health care,” by Alex Azar and…
Cattle testing for H5N1 bird flu will be more limited than USDA initially announced
New federal rules aimed at limiting the spread of the H5N1 bird flu virus among…
Computer scientists unveil novel attacks on cybersecurity
Researchers have found two novel types of attacks that target the conditional branch predictor found…
Biden administration punts menthol cigarette rule indefinitely
WASHINGTON — The Biden administration is walking away from a plan to permanently bar menthol cigarettes,…
STAT+: Momentum builds for House bill cracking down on Chinese biotechs
WASHINGTON — A House committee plans to mark up next month legislation that would restrict…
STAT+: Another hospital sues MultiPlan, alleging scheme to ‘suppress’ payments
MultiPlan is facing a new class action lawsuit that alleges the company and large health…
STAT+: Pharmalittle: We’re reading about Cigna biosimilar plans, a Vertex deal in South Africa, and more
And so, another working week will soon draw to a close. Not a moment too…
Advance in the treatment of acute heart failure identified
A multicenter study has identified a potential new treatment for acute heart failure, a leading…
Opinion: True peer-to-peer conversations will improve prior authorization
It’s another busy day in my spine surgery clinic when my phone rings. Patients are…
Opinion: Solving academic medical centers’ existential crisis
Hospitals and health care systems across the United States have long been expected to provide…
Mental health crisis centers and EmPATH units: offering care that busy ERs can’t
On a spring afternoon in Tucson, Ariz., about a half dozen children and teens hung…
Early trauma cuts life short for squirrels, and climate change could make matters worse
Life can be tough for young red squirrels living in the Canada’s Yukon territory, where…
Climate change could become the main driver of biodiversity decline by mid-century
Global biodiversity has declined between 2% and 11% during the 20th century due to land-use…
With hybrid brains, these mice smell like a rat
Mice lacking an olfactory system have had their sense of smell restored with neurons from…
Synthetic droplets cause a stir in the primordial soup
Our bodies are made up of trillions of different cells, each fulfilling their own unique…
How do birds flock? Researchers do the math to reveal previously unknown aerodynamic phenomenon
How do birds fly in a coordinated and seemingly effortless fashion? Part of the answer…
STAT+: Vertex offers limited access to a cystic fibrosis drug in South Africa — and may undercut a court case
After months of sustained criticism, Vertex Pharmaceuticals reached an agreement to provide a pricey cystic…
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
University of Washington professor David Baker has made a name for himself by borrowing computer…
STAT investigative series ‘Denied by AI’ wins major journalism prizes
Dear Readers, Please bear with me as I brag about two of STAT’s most accomplished…
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Andrew Bowman, a veterinary epidemiologist at Ohio State University had a hunch. He had been…
STAT+: Bernie Sanders targets ‘outrageously high price’ of Ozempic
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Washington kicks into gear on H5N1
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharmalittle: We’re reading about a Senate probe into Novo pricing, a new UTI antibiotic, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Profiting from ‘legal’ insider trading isn’t always easy
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers…
STAT Virtual Event | Tomorrow’s Trailblazers in Science
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future
Christopher Boerner, 53, took over as the chief executive officer of Bristol Myers Squibb last…
Opinion: Shortages of generic drugs can’t be blamed solely on group purchasing organizations
The Hatch-Waxman Act of 1984, which gave rise to the modern generic drug market, was…
STAT+: Generative AI is supposed to save doctors from burnout. New data show it needs more training
After stratospheric levels of hype, early evidence may be bringing generative artificial intelligence down to…
Opinion: The grim reality of relocating to get access to gender-affirming care
In my work as a pediatric psychologist, I’ve been seeing a surge in the number…
STAT+: Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
LONDON — Claire Booth, a gene therapy researcher in London, had hoped that a biotech…
STAT+: Equity, technology, and costs top of mind for life science’s leaders
Physicians, researchers, CEOs, reporters, and more gathered in downtown Boston Wednesday night to celebrate STAT’s…